Refine by
Coronavirus Sars Articles & Analysis
20 news found
Viral Vaccine Manufacturing to control pandemics: The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome–coronavirus 2 (SARS-CoV-2) has created a global public health crisis. ...
ByNuvonis
Prior studies indicate that high levels of IL-6 serve as an early indication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-induced hyperinflammation, disease severity, and multiorgan ...
(POP BIO) received a $599,981, two-year Phase I Small Business Innovation Research (SBIR) under Award No. 1R43AI165089-01, supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to pursue development of a potentially life-saving vaccine technology to address the ongoing pandemic crisis caused by Severe Acute Respiratory ...
Four-year agreement with Bill & Melinda Gates Foundation to discover and develop small molecule therapeutics with less susceptibility to variants and greater patient access than current approaches -- Exscientia to use leading AI platform and in-house drug expertise to discover and develop five phase 1-ready assets; Gates Foundation to contribute sector expertise in antivirals and global ...
The data demonstrate that a single adjuvant-free dose of MV-014-212 provided equivalent protection against SARS-CoV-2 challenge compared to reported efficacy in NHP models of currently authorized vaccines. ...
Safe Tourism Certified is a guarantee and certification accrediting compliance with the Technical Specification UNE 0066-19, which establishes the guidelines and recommendations for the reduction of the spread of SARS-CoV-2 coronavirus in the tourism sector related to the MICE ...
Food and Drug Administration (FDA) for a Phase 1 clinical study of MV-014-212, the company’s intranasal live attenuated chimeric vaccine candidate against SARS-CoV-2, the coronavirus that causes COVID-19. MV-014-212 offers significant potential advantages for COVID-19 vaccine global deployment, including needle-free intranasal administration, a single ...
According to its updated labels for all three states, EPA has now approved claims that SurfaceWise2 provides residual surface control of the coronavirus SARS-CoV-2 on surfaces that are undisturbed for up to 30 days. The updated labels state “When used in accordance with the directions for use, SurfaceWise®2 provides residual surface control of ...
The novel human coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to infect naïve populations causing surges of critically ill patients who can survive their acute critical illness. ...
ByCoapTech
This announcement follows up on EPA’s October 14, 2020, announcement that it would begin expediting its review of products with residual efficacy intended for use against SARS-CoV-2, the coronavirus that causes COVID-19. While traditional disinfectants only kill viruses and bacteria that are on the surface at the time they are used, surfaces treated with ...
Environmental Protection Agency (EPA) released much-anticipated draft guidance that will allow companies to demonstrate that their products have “long-lasting” or “residual” effectiveness on surfaces against viruses like SARS-CoV-2, the coronavirus that causes COVID-19. As most know, EPA has not before now provided guidance on how ...
While Zika retreated from view after 2016, the right conditions could bring it back, as we are experiencing in a parallel scenario with the SARS coronavirus which disappeared after the 2003 outbreak, only to reappear now in a more virulent form. ...
The SSUROs address over 30 products sold on Amazon and over 40 products sold on eBay, and include several products marketed with what EPA believes are false or misleading claims of efficacy against the novel coronavirus, SARS-CoV-2, the cause of COVID-19. EPA notes that Amazon and eBay are two of the largest e-commerce marketplaces and that they oversee ...
To expedite such analysis, Thermo Fisher Scientific has now optimized its Ion AmpliSeq SARS-CoV-2 Research Panel for the Ion Torrent Genexus System. Next-generation sequencing (NGS) provides scientists a high-throughput method to quickly analyze the virus' genetic code and trace its origin. ...
This type of collaborative investigative effort among federal agencies can be expected to continue to prevent defrauding victims during this coronavirus pandemic. In its press release announcing the arrest, DOJ stated that it “will take quick action through the Georgia COVID-19 Task Force to put a stop to criminals preying on the public with ...
Elsevier, a global leader in information analytics specializing in science and health, has launched a new resource to aid healthcare workers on the front lines of managing the novel coronavirus health crisis. The COVID-19 Healthcare Hub provides free access to toolkits, expert insights, research resources and COVID-19 guidelines. ...
With over 800,000 people across the globe, including approximately 170,000 residents of the United States, known to be infected with the novel coronavirus (SARS-CoV-2), the pandemic has tragically already resulted in the deaths of tens of thousands of people. ...
The health of our employees, business partners and the general public are very important to us We are taking the global health crisis caused by the coronavirus (SARS-CoV-2) very seriously and are doing our bit to slow down the spread of the virus. ...
As scientists scramble to learn more about the SARS-CoV-2 coronavirus, two recent studies of the virus’ genome reached controversial conclusions: namely, that snakes are intermediate hosts of the new virus, and that a key coronavirus protein shares “uncanny similarities” with an HIV-1 protein. ...
Their newest production discusses coronavirus disease 2019 (COVID-19) and the SARS-CoV-2 virus. “The coronavirus pandemic has impacted people’s lives in many ways in countries across the globe,” said Paul Cochrane, President of Cochrane and Associates and the IAQ Video Network. ...